Insider Trading activities of Lifeline Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lifeline Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lifeline Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Lifeline Therapeutics, Inc. since 2005. The reporting company's ticker symbol is LFVN. The reporting company's CIK number is 849146.
The total value of stock buying since 2005 is $2,047,383.
The total value of stock sales since 2005 is $1,488,948.
The total value of stock option exercises since 2005 is $489,300.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Lifeline Therapeutics, Inc. (LFVN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-09 9,400 $39,819 0 $0 0 $0
2017-05 2,000 $8,680 0 $0 0 $0
2017-02 11,173 $75,120 0 $0 0 $0
2015-12 3,500 $28,140 0 $0 7,466 $0
2015-11 689 $5,841 0 $0 0 $0
2015-09 5,000 $3,750 0 $0 0 $0
2015-04 0 $0 20,252 $15,715 0 $0
2015-03 5,000 $3,900 0 $0 0 $0
2015-02 2,600 $2,652 0 $0 0 $0
2014-09 8,000 $10,000 0 $0 0 $0
2014-05 0 $0 0 $0 100,000 $133,000
2013-12 10,400 $20,176 0 $0 0 $0
2013-11 50,000 $90,500 0 $0 0 $0
2013-05 50,000 $122,000 0 $0 0 $0
2013-04 0 $0 7,000 $16,639 0 $0
2012-09 31,620 $106,043 0 $0 0 $0
2012-03 72,000 $203,340 0 $0 0 $0
2012-02 20,000 $36,286 0 $0 490,000 $264,200
2011-12 5,061 $6,923 394,875 $565,642 120,000 $43,200
2009-10 0 $0 0 $0 185,000 $37,350
2009-04 300,000 $60,000 0 $0 15,000 $3,150
2009-03 650,000 $130,000 0 $0 0 $0
2008-12 20,000 $1,900 0 $0 0 $0
2008-11 40,000 $4,100 0 $0 0 $0
2008-06 0 $0 0 $0 10,000 $2,100
2008-05 0 $0 0 $0 10,000 $2,100
2008-04 0 $0 0 $0 10,000 $2,100
2008-03 0 $0 0 $0 10,000 $2,100
2006-03 80,000 $139,600 0 $0 0 $0
2005-07 550,000 $748,000 550,000 $748,000 0 $0
2005-05 75,000 $150,000 0 $0 0 $0
2005-04 55,434 $50,613 285,904 $142,952 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Lifeline Therapeutics, Inc. insiders (LFVN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-09-15 Lewis Darwin Buy 3,500 4.29 15,015
2017-09-15 Mauro Garry Paul Buy 3,500 4.20 14,700
2017-09-12 Jensen Darren Jay (Chief Executive Officer) Buy 2,400 4.21 10,104
2017-05-18 Jensen Darren Jay (Chief Executive Officer) Buy 2,000 4.34 8,680
2017-02-14 Beindorff Michael A Buy 438 6.50 2,847
2017-02-13 Rose Justin (Chief Sales Officer) Buy 1,500 6.75 10,125
2017-02-13 Jensen Darren Jay (Chief Executive Officer) Buy 1,500 6.75 10,125
2017-02-13 Metzger George Buy 1,000 6.63 6,630
2017-02-13 Mauro Garry Paul Buy 2,435 6.74 16,416
2017-02-13 Beindorff Michael A Buy 2,300 6.79 15,617
2017-02-13 Toole David J Buy 2,000 6.68 13,360
2015-12-31 Urban Robert M. (Chief Operating Officer) Option Ex 7,466 .00 0
2015-12-11 Jaggi Mark R. (Chief Financial Officer) Buy 1,000 7.99 7,990
2015-12-10 Metzger George Buy 2,500 8.06 20,150
2015-11-30 Jensen Darren Jay (Chief Executive Officer) Buy 600 8.48 5,088
2015-11-11 Beindorff Michael A Buy 89 8.47 753
2015-09-14 Urban Robert M. (Chief Operating Officer) Buy 5,000 .75 3,750
2015-04-06 Cutler Rob (General Counsel) Sale 20,252 .78 15,715
2015-03-10 Beindorff Michael A Buy 5,000 .78 3,900
2015-02-17 Talbott Shawn M. (Chief Science Officer) Buy 2,600 1.02 2,652
2014-09-15 Talbott Shawn M. (Chief Science Officer) Buy 8,000 1.25 10,000
2014-05-22 Metzger George Option Ex 100,000 1.33 133,000
2013-12-02 Beindorff Michael A Buy 10,400 1.94 20,176
2013-11-22 Okumoto Richard Y Buy 50,000 1.81 90,500
2013-05-14 Okumoto Richard Y (Director) Buy 50,000 2.44 122,000
2013-04-01 Cutler Rob (General Counsel) Sale 7,000 2.38 16,639
2012-09-14 Thompson Ryan (Senior VP of Sales) Buy 2,920 3.39 9,898
2012-09-14 Beindorff Michael A (Director) Buy 28,700 3.35 96,145
2012-03-15 Beindorff Michael A (Director) Buy 10,000 2.77 27,750
2012-03-14 Beindorff Michael A (Director) Buy 40,000 3.10 124,200
2012-03-09 Beindorff Michael A (Director) Buy 3,400 2.74 9,316
2012-03-06 Beindorff Michael A (Director) Buy 12,500 2.27 28,437
2012-03-05 Beindorff Michael A (Director) Buy 5,000 2.25 11,250
2012-03-02 Beindorff Michael A (Director) Buy 1,100 2.17 2,387
2012-02-23 Beindorff Michael A (Director) Buy 10,000 1.82 18,250
2012-02-22 Beindorff Michael A (Director) Buy 4,200 1.85 7,770
2012-02-21 Beindorff Michael A (Director) Buy 5,800 1.77 10,266
2012-02-14 Manovich Dave (Director) Option Ex 240,000 .58 139,200
2012-02-09 Mauro Garry Paul (Director) Option Ex 150,000 .50 75,000
2012-02-09 Brown David Whitney (President, LifeVantage Network) Option Ex 50,000 .50 25,000
2012-02-03 Brown David Whitney (President, LifeVantage Network) Option Ex 50,000 .50 25,000
2011-12-14 Mauro Garry Paul (Director) Buy 5,061 1.37 6,923
2011-12-13 Robinson Douglas C. (President & CEO) Sale 120,000 1.43 171,600
2011-12-13 Robinson Douglas C. (President & CEO) Option Ex 120,000 .36 43,200
2011-12-13 Brown David Whitney (President, LifeVantage Network) Sale 100,000 1.43 143,000
2011-12-13 Crapo James D (Director) Sale 80,185 1.43 114,664
2011-12-07 Crapo James D (Director) Sale 12,556 1.45 18,256
2011-12-06 Crapo James D (Director) Sale 8,700 1.43 12,449
2011-12-05 Crapo James D (Director) Sale 56,934 1.44 81,814
2011-12-02 Crapo James D (Director) Sale 16,500 1.45 23,859
2009-10-27 Thompson Jack R. (Director) Option Ex 35,000 .21 7,350
2009-10-01 Thompson Jack R. (Director) Option Ex 150,000 .20 30,000
2009-04-27 Thompson Jack R. (Director) Option Ex 15,000 .21 3,150
2009-04-07 Jones Richard Doutre (Director) Buy 100,000 .20 20,000
2009-04-07 Brown David Whitney (Chief Executive Officer) Buy 100,000 .20 20,000
2009-04-07 Amman Bradford K. (CFO, Treasurer, Secretary) Buy 50,000 .20 10,000
2009-04-07 Crapo James D (Director) Buy 50,000 .20 10,000
2009-03-11 Mauro Garry Paul (Director) Buy 150,000 .20 30,000
2009-03-11 Thompson Jack R. (Director) Buy 500,000 .20 100,000
2008-12-05 Thompson Jack R. (Director) Buy 20,000 .10 1,900
2008-11-19 Thompson Jack R. (Director) Buy 20,000 .10 2,100
2008-11-18 Thompson Jack R. (Director) Buy 20,000 .10 2,000
2008-06-03 Thompson Jack R. (Director) Option Ex 10,000 .21 2,100
2008-05-06 Thompson Jack R. (Director) Option Ex 10,000 .21 2,100
2008-04-10 Thompson Jack R. (Director) Option Ex 10,000 .21 2,100
2008-03-03 Thompson Jack R. (Director) Option Ex 10,000 .21 2,100
2006-03-23 Heuvelen John Van (Director) Buy 80,000 1.75 139,600
2005-07-06 Myhill Paul Robert (VP, Treasurer, Secre) Sale 550,000 1.36 748,000
2005-07-06 Crapo James D (Director) Buy 550,000 1.36 748,000
2005-05-16 Crapo James D (Director) Buy 25,000 2.00 50,000
2005-05-16 Severance H Leigh (Director) Buy 25,000 2.00 50,000
2005-05-15 Krejci James (Director) Buy 25,000 2.00 50,000
2005-04-18 Heuvelen John Van (Director) Buy 15,264 2.00 30,528
2005-04-04 Streets Daniel W (Treasurer, Secretary) Buy 40,170 .50 20,085
2005-04-04 Driscoll William Joseph (President, CEO) Sale 285,904 .50 142,952

Insider trading activities including stock purchases, stock sales, and option exercises of LFVN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lifeline Therapeutics, Inc. (symbol LFVN, CIK number 849146) see the Securities and Exchange Commission (SEC) website.